Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for neurological sequelae after ischemic stroke
IRCT2017041720258N37Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fluoxetine in ischemic stroke, sponsored by Arak University of Medical Sciences. Started Feb 2017; status: completed.
02
Drugs
fluoxetine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT2017041720258N37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017041720258N37.